Concepedia

Hatice Yücel

HY

5

Publications

819

Citations

5

H-Index

2016

Active since

Affiliations

The Netherlands Cancer Institute(Current)

Dana-Farber Cancer Institute

Harvard University

Inserm

The University of Texas MD Anderson Cancer Center

Hatice Yücel is an author at The Netherlands Cancer Institute specializing in molecular biology, medicine, and tumor biology.

Top concepts

Publications per year

2016–2021

5

Publications

5

EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation

Beatrice Rondinelli, Ewa Gogola, Hatice Yücel et al. · Nature Cell Biology · 2017 · 322 citations · Full text

, , +12

A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors

Jia Zhou, Camille Gelot, Constantia Pantelidou et al. · Nature Cancer · 2021 · 320 citations · Full text

, , +3

Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland

Stefano Annunziato, Sjors M. Kas, Micha Nethe et al. · Genes & Development · 2016 · 146 citations · Full text

, , +19

Polymerase Theta Inhibition Kills Homologous Recombination Deficient Tumors

Jia Zhou, Camille Gelot, Constantia Pantelidou et al. · 2020 · 17 citations · Full text

, , +15

Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model

Gerben R. Borst, Ramya Kumareswaran, Hatice Yücel et al. · Oncotarget · 2017 · 14 citations · Full text

Rows per page

1–5 of 5